Cardiac monitoring in HER2-positive patients on trastuzumab treatment: A review and implications for clinical practice

por Bouwer, Nathalie I., Jager, Agnes, Liesting, Crista, Kofflard, Marcel J.M., Brugts, Jasper J., Kitzen, Jos J.E.M., Boersma, Eric, Levin, Mark-David
Publicado 2020

2D-echocardiography vs cardiac MRI strain: a prospective cohort study in patients with HER2-positive breast cancer undergoing trastuzumab

por Bouwer, Nathalie I., Liesting, Crista, Kofflard, Marcel J. M., Brugts, Jasper J., Kock, Marc C. J., Kitzen, Jos J. E. M., Levin, Mark-David, Boersma, Eric
Publicado 2021

NT-proBNP correlates with LVEF decline in HER2-positive breast cancer patients treated with trastuzumab

por Bouwer, Nathalie I., Liesting, Crista, Kofflard, Marcel J. M., Sprangers-van Campen, Sylvia M., Brugts, Jasper J., Kitzen, Jos J. E. M., Fouraux, Michael A., Levin, Mark-David, Boersma, Eric
Publicado 2019